Protein kodiran ovim genom je član TNF familije receptora. On je izražen na površini većine ćelijskih tipova, uključujući ćelije epitelnog i mijeloidnog porekla, ali ne na T i Blimfocitima. Ovaj protein specifično vezuje limfotoksin membransku formu (kompleks limfotoksina-alfa i limftoksina-beta se formira). Limftoksin-beta i njegov ligand učestvuju u razvoju i organizaciji limfoidnog tkiva. Aktivacija ovog proteina može da podstakne apoptozu.[2]
Ne samp da LTBR pomaže u podsticanju apoptoze, on može da dovede do oslobađanja citokinainterleukin 8. Prekomerno LTBR izražavanje u HEK293 ćelima povećava IL-8 promotorsku aktivnost, i dovodi do IL-8 oslobađanja. LTBR je takođe esencijalan za razvoj i organizaciju sekundarnih limfoidnih organa i oslobađanje drugih hemokina.[5]
Ramačandranov dijagram pokazuje da je 64.6% ostataka u poželjnom regionu.[6] Ova structura je ustanovljena putem difrakcije X-zraka. Njena rezolucija je 3.50 Å. Alfa i beta uglovi su 90 stepeni, dok je gama ugao 120 stepeni.
↑Baens M, Chaffanet M, Cassiman JJ, van den Berghe H, Marynen P (April 1993). „Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid”. Genomics16 (1): 214–8. DOI:10.1006/geno.1993.1161. PMID8486360.
↑Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (April 1994). „A lymphotoxin-beta-specific receptor”. Science (journal)264 (5159): 707–10. DOI:10.1126/science.8171323. PMID8171323.
↑Chang YH, Hsieh SL, Chen MC, Lin WW (August 2002). „Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation”. Exp. Cell Res.278 (2): 166–74. DOI:10.1006/excr.2002.5573. PMID12169272.
↑Kuai, Jun; Nickbarg Elliott, Wooters Joe, Qiu Yongchang, Wang Jack, Lin Lih-Ling (April 2003). „Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis”. J. Biol. Chem. (United States) 278 (16): 14363–9. DOI:10.1074/jbc.M208672200. ISSN0021-9258. PMID12571250.
↑Wu, M Y; Wang P Y, Han S H, Hsieh S L (April 1999). „The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells”. J. Biol. Chem. (UNITED STATES) 274 (17): 11868–73. DOI:10.1074/jbc.274.17.11868. ISSN0021-9258. PMID10207006.
↑Marsters, S A; Ayres T M, Skubatch M, Gray C L, Rothe M, Ashkenazi A (May 1997). „Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1”. J. Biol. Chem. (UNITED STATES) 272 (22): 14029–32. DOI:10.1074/jbc.272.22.14029. ISSN0021-9258. PMID9162022.
Browning JL, Ngam-ek A, Lawton P, et al. (1993). „Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.”. Cell72 (6): 847–56. DOI:10.1016/0092-8674(93)90574-A. PMID7916655.
Crowe PD, VanArsdale TL, Walter BN, et al. (1994). „A lymphotoxin-beta-specific receptor.”. Science264 (5159): 707–10. DOI:10.1126/science.8171323. PMID8171323.
Baens M, Chaffanet M, Cassiman JJ, et al. (1993). „Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid.”. Genomics16 (1): 214–8. DOI:10.1006/geno.1993.1161. PMID8486360.
Baens M, Aerssens J, van Zand K, et al. (1996). „Isolation and regional assignment of human chromosome 12p cDNAs.”. Genomics29 (1): 44–52. DOI:10.1006/geno.1995.1213. PMID8530100.
Wang X, Bornslaeger EA, Haub O, et al. (1996). „A candidate gene for the amnionless gastrulation stage mouse mutation encodes a TRAF-related protein.”. Dev. Biol.177 (1): 274–90. DOI:10.1006/dbio.1996.0162. PMID8660894.
Nakano H, Oshima H, Chung W, et al. (1996). „TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.”. J. Biol. Chem.271 (25): 14661–4. DOI:10.1074/jbc.271.25.14661. PMID8663299.
Wu MY, Hsu TL, Lin WW, et al. (1997). „Serine/threonine kinase activity associated with the cytoplasmic domain of the lymphotoxin-beta receptor in HepG2 cells.”. J. Biol. Chem.272 (27): 17154–9. DOI:10.1074/jbc.272.27.17154. PMID9202035.
Mizushima S, Fujita M, Ishida T, et al. (1998). „Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5).”. Gene207 (2): 135–40. DOI:10.1016/S0378-1119(97)00616-1. PMID9511754.
Boussaud V, Soler P, Moreau J, et al. (1999). „Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung.”. Eur. Respir. J.12 (4): 926–31. DOI:10.1183/09031936.98.12040926. PMID9817170.
Murphy M, Walter BN, Pike-Nobile L, et al. (1999). „Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.”. Cell Death Differ.5 (6): 497–505. DOI:10.1038/sj.cdd.4400374. PMID10200501.
Wu MY, Wang PY, Han SH, Hsieh SL (1999). „The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells.”. J. Biol. Chem.274 (17): 11868–73. DOI:10.1074/jbc.274.17.11868. PMID10207006.
Yu KY, Kwon B, Ni J, et al. (1999). „A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.”. J. Biol. Chem.274 (20): 13733–6. DOI:10.1074/jbc.274.20.13733. PMID10318773.
Rooney IA, Butrovich KD, Glass AA, et al. (2000). „The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.”. J. Biol. Chem.275 (19): 14307–15. DOI:10.1074/jbc.275.19.14307. PMID10799510.
Langeggen H, Berge KE, Johnson E, Hetland G (2003). „Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.”. Inflammation26 (3): 103–10. DOI:10.1023/A:1015585530204. PMID12083416.
Chang YH, Hsieh SL, Chen MC, Lin WW (2002). „Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation.”. Exp. Cell Res.278 (2): 166–74. DOI:10.1006/excr.2002.5573. PMID12169272.